StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$27.40−2.96 (-9.75%)

Close on Nov 17, 2026Market cap $2.64BP/E –Yield –

IDEAYA Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

IDEAYA Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$111.66M. For fiscal 2025 it was -$71.10M. The highest annual figure on record is $55.46M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$71.10M–
FY2024Dec 31, 2024-$247.58M–
FY2023Dec 31, 2023-$115.22M–
FY2022Dec 31, 2022-$87.18M–
FY2021Dec 31, 2021-$55.78M-200.6%
FY2020Dec 31, 2020$55.46M–
FY2019Dec 31, 2019-$39.31M–
FY2018Dec 31, 2018-$27.62M–
FY2017Dec 31, 2017-$12.22M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$88.21M–
Q1 FY2026Mar 31, 2026-$75.17M–
Q4 FY2025Dec 31, 2025-$90.50M–
Q3 FY2025Sep 30, 2025$142.21M–
Q2 FY2025Jun 30, 2025-$62.47M–
Q1 FY2025Mar 31, 2025-$60.34M–
Q4 FY2024Dec 31, 2024-$121.66M–
Q3 FY2024Sep 30, 2024-$49.23M–
Q2 FY2024Jun 30, 2024-$32.88M–
Q1 FY2024Mar 31, 2024-$43.81M–
Q4 FY2023Dec 31, 2023-$23.75M–
Q3 FY2023Sep 30, 2023-$30.17M–
Q2 FY2023Jun 30, 2023-$33.46M–
Q1 FY2023Mar 31, 2023-$27.84M–
Q4 FY2022Dec 31, 2022-$23.37M–
Q3 FY2022Sep 30, 2022-$24.17M–
Q2 FY2022Jun 30, 2022-$19.99M–
Q1 FY2022Mar 31, 2022-$19.65M–
Q4 FY2021Dec 31, 2021-$16.66M–
Q3 FY2021Sep 30, 2021-$12.47M-113.8%
Q2 FY2021Jun 30, 2021-$12.93M–
Q1 FY2021Mar 31, 2021-$13.72M–
Q4 FY2020Dec 31, 2020-$11.60M–
Q3 FY2020Sep 30, 2020$90.21M–
Q2 FY2020Jun 30, 2020-$13.61M–
Q1 FY2020Mar 31, 2020-$9.55M–
Q4 FY2019Dec 31, 2019-$8.71M–
Q3 FY2019Sep 30, 2019-$10.55M–
Q2 FY2019Jun 30, 2019-$10.27M–
Q1 FY2019Mar 31, 2019-$9.79M–
Q4 FY2018Dec 31, 2018-$7.48M–
Q3 FY2018Sep 30, 2018-$8.69M–

More IDEAYA Biosciences figures

See a number that looks wrong?